Researchers in Hong Kong are reporting the first confirmed case of a person being reinfected with COVID-19.
They say a 33-year-old man first recovered in April from the virus and after returning from Spain this month has tested positive again.
The man was asymptomatic during this second infection.
Researchers say the genetic sequencing showed the virus strains April and august were ‘clearly different’ – which is of concern because they say it suggests that immunity to the coronavirus may last only a few months in some people.
Doctors say this will also have implications for vaccines being developed for the virus.
The man had mild symptoms the first time and none the second time; his more recent infection was detected through screening and testing at the Hong Kong airport.
“It shows that some people do not have lifelong immunity” to the virus if they’ve already had it,” said Dr. Kelvin Kai-Wang To, the microbiologist who led the work. “We don’t know how many people can get reinfected. There are probably more out there.”
The paper has been accepted by the journal Clinical Infectious Diseases but not yet published, and some independent experts urged caution until full results are available.
Whether people who have had COVID-19 are immune to new infections and for how long are key questions that have implications for vaccine development and decisions about returning to work, school and social activities.
Even if someone can be infected a second time, it’s not known if they have some protection against serious illness, because the immune system generally remembers how to make antibodies against a virus it’s seen before.
It’s not clear how different a virus needs to be to trigger illness, but the new work suggests that “COVID patients should not be complacent about prevention measures” and should continue social distancing, wearing masks and other ways to reduce infection, To said.
Two experts with no role in the work agreed.
“We’ve always known reinfection was a possibility and I think this is highly suggestive” that it occurred in this case, said Dr. Jesse Goodman, a former U.S. Food and Drug Administration chief scientist now at Georgetown University. “If there is a reinfection, it suggests the possibility there was residual immunity … that helped protect the patient” from getting sick again, Goodman said.
However, “if immunity wanes from natural infection, it could be a challenge for vaccines” and may mean booster shots are needed, he added.
Julie Fischer, a microbiologist at CRDF Global, a nonprofit health group in Arlington, Virginia, said the study gives convincing evidence that reinfection can happen.
“The real question is what this means for severity of disease” if that occurs, and whether such people can infect others, she said.
One expert saw the report as good news. Dr. Paul Offit, a vaccine expert at Children’s Hospital of Philadelphia, said it’s encouraging the reported reinfection was without symptoms.
“That’s a win as far as I’m concerned” because it suggests a first infection may protect a person from moderate to severe disease the second time around, he said in an interview streamed by the Journal of the American Medical Association.
A mid-May survey by the doctors’ information-sharing site Sermo found that 13 per cent of the 4,173 doctors responding believed that they had treated one or more patients who were reinfected. Among the respondents, 7 per cent of those in the U.S. and 16 per cent in other countries thought they’d seen such a case.
However, health officials have also wondered whether people who tested positive long after their initial illness were simply showing signs of not completely clearing the virus rather than being infected anew.